Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN
· Real-Time Price · USD
8.00
0.48 (6.38%)
At close: Aug 15, 2025, 3:47 PM
7.94
-0.75%
After-hours: Aug 15, 2025, 04:00 PM EDT
Addex Therapeutics Ltd Balance Sheet Statement
Financials in CHF. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.83M | 3.34M | 3.35M | 3.79M | 1.63M | 3.87M | 4.75M | 7.17M | 5.59M | 6.96M | 10.42M | 8.81M | 14.89M | 20.48M | 15.49M | 18.11M | 25.22M |
Short-Term Investments | 6.83K | 6.5K | 4.95K | 2.8K | 2.38K | 848.00 | 426.00 | 16.74K | 4.12K | 3.17K | 3.08K | 3.56K | 8.59K | 17.14K | 27.96K | 38.3K | 9.96K |
Long-Term Investments | 6.24M | 7.09M | 8.02M | 8.9M | n/a | n/a | 54.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 7.09K | 7.09K | 7.06K | 7.07K | 7.07K | 54.34K | n/a | 54.35K | 54.35K | 54.35K | 59.58K | 58.08K | 57.95K | 57.91K | 57.99K | -472.2K | 59.47K |
Receivables | 35.36K | 15.51K | 516.51K | 616.43K | 225.05K | 151.27K | 373.37K | 502.28K | 431.47K | 598.32K | 457.04K | 410.02K | 434.63K | 324.42K | 582.47K | 1.23M | 183.72K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 7.97K | 5K | 5K | 789.88K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 3.2M | 3.54M | 4.07M | 4.69M | 3.29M | 4.23M | 5.74M | 8.69M | 6.91M | 7.83M | 11.7M | 10.95M | 17.16M | 21.94M | 17.44M | 21M | 26.27M |
Property-Plant & Equipment | 40.59K | 42.71K | 44.83K | 29.38K | 32.32K | 352.94K | 341.05K | 252.51K | 325.42K | 398.73K | 481.38K | 377.84K | 461.18K | 542.1K | 566.01K | 472.2K | 548.8K |
Goodwill & Intangibles | n/a | n/a | 21.68K | 72.9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 6.29M | 7.14M | 8.1M | 9.01M | 39.39K | 407.28K | 395.39K | 306.86K | 379.78K | 453.09K | 540.96K | 435.91K | 519.13K | 600.01K | 624.01K | 531.57K | 608.27K |
Total Assets | 9.48M | 10.68M | 12.17M | 13.7M | 3.33M | 4.64M | 6.14M | 9M | 7.29M | 8.28M | 12.24M | 11.38M | 17.68M | 22.54M | 18.06M | 21.53M | 26.87M |
Account Payables | 286.13K | 253.29K | 325.78K | 302.38K | 1.63M | 984.38K | 389.78K | 1.11M | 1.08M | 1.28M | 2.99M | 1.82M | 1.42M | 1.79M | 1.16M | 1.21M | 2.23M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 234.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 110.74K | -258.67K | 13.36K |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 101.24K | n/a | n/a | n/a | 1.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 1.06M | 802.09K | 887.56K | 942.99K | 4.65M | 2.89M | 1.93M | 2.71M | 3.19M | 3.28M | 4.13M | 4.3M | 3.97M | 4.13M | 3.27M | 3.68M | 4.61M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 99.36K | 164.25K | 181.91K | 83.11K | 31.53K | 532.76K | 145.77K | 125.86K | n/a | n/a | n/a | 129.28K | 632.75K | 1.28M | 1.22M | 1.26M | 1.38M |
Total Long-Term Liabilities | 132.16K | 198.94K | 218.47K | 102.9K | 54.48K | 603.14K | 262.67K | 158.5K | 36.33K | 87.03K | 161.18K | 223.44K | 753.52K | 1.48M | 1.45M | 1.42M | 1.56M |
Total Liabilities | 1.19M | 1M | 1.11M | 1.05M | 4.71M | 3.5M | 2.19M | 2.87M | 3.22M | 3.37M | 4.29M | 4.52M | 4.73M | 5.61M | 4.72M | 5.11M | 6.18M |
Total Debt | 40.2K | 41.99K | 43.77K | 32.18K | 35.19K | 344.34K | 323.32K | 232.52K | 259.12K | 373.13K | 447.11K | 336.95K | 412.87K | 482.01K | 521.22K | 420.16K | 489.8K |
Common Stock | 1.84M | 1.84M | 1.84M | 1.84M | 1.84M | 1.84M | 1.42M | 1.36M | 1.15M | 1.15M | 652.73K | 65.27M | 65.27M | 49.27M | 49.27M | 49.27M | 39.75M |
Retained Earnings | -354.84M | -353.36M | -352.16M | -350.63M | -363.51M | -360.42M | -357.56M | -354.94M | -352.27M | -349.86M | -346.21M | -342.1M | -334.88M | -329.06M | -324.63M | -321.04M | -316.35M |
Comprehensive Income | 31.15M | 31.06M | 31.24M | 31.31M | 94.77M | 29.81M | 31.67M | 32.06M | 26.17M | 25.77M | 26.7M | 27.65M | 26.51M | 24.44M | 15.9M | 15.43M | 8.9M |
Shareholders Equity | 8.3M | 9.68M | 11.06M | 12.65M | -1.38M | 1.15M | 3.94M | 6.13M | 4.07M | 4.91M | 7.95M | 6.86M | 12.96M | 16.93M | 13.34M | 16.42M | 20.7M |
Total Investments | 6.25M | 7.09M | 8.03M | 8.9M | 2.38K | 848.00 | 426.00 | 16.74K | 4.12K | 3.17K | 3.08K | 3.56K | 8.59K | 17.14K | 27.96K | 38.3K | 9.96K |